TrianglePUBLICATIONS · 12953086
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Natl Cancer Inst
- Publication date
- 2003 Sep 3
- First author
- du Bois A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- du Bois A
- type
- Author
- name
- Lück HJ
- type
- Author
- name
- Meier W
- type
- Author
- name
- Adams HP
- type
- Author
- name
- Möbus V
- type
- Author
- name
- Costa S
- type
- Author
- name
- Bauknecht T
- type
- Author
- name
- Richter B
- type
- Author
- name
- Warm M
- type
- Author
- name
- Schröder W
- type
- Author
- name
- Olbricht S
- type
- Author
- name
- Nitz U
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- du Bois A
- type
- Author
- name
- Lück HJ
- type
- Author
- name
- Meier W
- type
- Author
- name
- Adams HP
- type
- Author
- name
- Möbus V
- type
- Author
- name
- Costa S
- type
- Author
- name
- Bauknecht T
- type
- Author
- name
- Richter B
- type
- Author
- name
- Warm M
- type
- Author
- name
- Schröder W
- type
- Author
- name
- Olbricht S
- type
- Author
- name
- Nitz U
- type
- Author
- bibliography ids
- nci-bib-e33916bc110e83d51bf702c8
- book metadata
- content sha256
- 14559fd0a7a150cb0f63b76ba325bf9cccb2f5ea0c3f77d24b662bf17aed3ccf
- document type
- citation
- dois
- 10.1093/jnci/djg036
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12953086
- immutable id
- pubmed:12953086@14559fd0a7a150cb0f63b76ba325bf9cccb2f5ea0c3f77d24b662bf17aed3ccf
- journal
- abbreviation
- J Natl Cancer Inst
- issn electronic
- 1460-2105
- issn print
- 0027-8874
- issue
- 17
- name
- Journal of the National Cancer Institute
- nlm unique id
- 7503089
- pages
- 1320-9
- volume
- 95
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12953086
- provenance
- batch id
- 2d0158fe73b50bb1a4bf
- provider
- NCBI PubMed ESummary
- record sha256
- 25b4a537e974ca424671e9bee9ea966d8b2e28307817625a825801098c6f64d4
- response sha256
- d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
- retrieved at
- 2026-09-09T23:45:50.935339+00:00
- publication date
- display
- 2003 Sep 3
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.
Preserved source evidence · Not medical advice